About this article Cite this article Vinten, K.T., Trtowicz, M.M., Coskun, E
Which Grade is poised to lead global sales by 2026
Not to mention the indication expansion into MASH, sleep apnea, addiction, and neurodegenerative diseases
(Source: iPharma Pharmacy, 2026) A 2026 systematic review and meta-analysis (Prospero CRD42024535096) searched Cochrane Library, EMBASE, and Medline through September 2024, identifying 9,654 studies and including 11 randomized controlled trials comparing GLP-1 receptor agonists against no treatment, placebo, lifestyle intervention, oral contraceptives, anti-androgens, or metformin in PCOS patients
GI side effects can also disrupt sleep and movement